CPV-104, a Recombinant Variant of Human Complement Factor H Produced in Moss, to Be Studied in a Phase 1/2 Clinical Trial in Patients with C3 Glomerulopathy (C3G): SA-PO918
Heidenreich, Karin, Cochlovius, Björn, Bauer, Martin, Busch, Andreas, Dabrowska-Schlepp, Paulina, Schaaf, Andreas, Zeitter, Fabienne C., Häffner, Karsten, Koehl, Joerg, Schmidt, Tilman, Wiech, Thorsten, Zipfel, Peter F.
Published in Journal of the American Society of Nephrology (01.11.2023)
Published in Journal of the American Society of Nephrology (01.11.2023)
Get full text
Journal Article